
Sign up to save your podcasts
Or


Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719
By Michael Putman4.9
114114 ratings
Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719

502 Listeners

300 Listeners

124 Listeners

3,383 Listeners

1,151 Listeners

121 Listeners

196 Listeners

517 Listeners

66 Listeners

5 Listeners

378 Listeners

184 Listeners

188 Listeners

20 Listeners

6 Listeners